Houman Kaghazian told Mehr News correspondent that the BCG (Bacillus Calmette-Guérin) vaccine which protects against tuberculosis (TB) has been produced at Pasteur Institute of Iran (IPI) for many years; “we have also increased the volume of the BCG vaccine production while the World Health Organization is investigating Iran's vaccine case.”
He noted that once the WHO approves of a vaccine, the product can be exported to all over the world, adding “we have submitted the files of our produced BCG vaccine to the WHO and are currently waiting for them to complete their study on it.”
Kaghazian maintained that once Iran obtains the necessary certificates for producing the vaccine from the WHO, the country can export the product to countries in need of the vaccine.
So far, no vaccine produced in Iran has managed to obtain an export certificate from the WHO, and the case of the BCG vaccine could be the first time the country would be able to export its vaccines to other countries.
Noting that the quality of vaccines produced in Iran is so much higher than that in some other countries, Kaghazian added that the Pasteur Institute has been producing the BCG vaccine for 50 years; “we have recently planned to pursue the qualitative measures on this vaccine,” he said.
According to him, the WHO will issue the certificate by the end of 2016 and Iran will then start exporting the vaccine to any country who is in need of it.
MS/2987697
Your Comment